Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04PGO
|
||||
Former ID |
DIB005787
|
||||
Drug Name |
MDL-28133A
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Thromboembolism [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Terminated | [1] | ||
Company |
Hoechst Marion Roussel Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C21H24ClFN2O4S
|
||||
Canonical SMILES |
S(=O)(=O)(Nc1ccc(C(=O)C2CCN(CC(=O)c3ccc(cc3)F)CC2)cc1)C<br />.Cl
|
||||
CAS Number |
CAS 136861-96-6
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-HT 2 receptor | Target Info | Modulator | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Serotonergic synapse | |||||
Inflammatory mediator regulation of TRP channels | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002814) | ||||
REF 2 | Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs. J Cardiovasc Pharmacol. 1994 Nov;24(5):761-72. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.